ClinicalTrials.Veeva

Menu

Voice Activated Personal Assistant for Depression Among Older Adults

Northwestern University logo

Northwestern University

Status

Enrolling

Conditions

Depression, Anxiety

Treatments

Behavioral: Alexa with Guidebook
Behavioral: VIPA Treatment Program

Study type

Interventional

Funder types

Other

Identifiers

NCT06114485
STU#: 00211894

Details and patient eligibility

About

Participants will use Amazon Alexa to test a new voice-assisted program for mental health management. The participant will use this program to help with goal setting, reminders, and various other services. The participant may be supported by a caregiver, if available, or by research team member who will serve as a coach for the duration of the study to guide them with using the program. Participants will be asked to complete surveys and assessments about their experiences during the 12-week study period. Participants will be randomized into two groups: those who receive a guide to help them with utilization of the program to its fullest potential and those who do not receive that guide.

Full description

Older adults have often been on the fringe of benefiting from technology. However, voice-controlled intelligent personal assistants (VIPAs; e.g. Google Home, Amazon Echo), with their natural interaction style and ease of use, are a simple interface technology that may be useful to older adults with depression in the home setting. The caregiver or coach will be able to schedule and follow the interactions between the older adult and the VIPA. The VIPAs would potentially be able to provide functional, cognitive, and social stimulation as well as improve anti-depressant medication adherence through reminders to older adults.

The aim is to evaluate a VIPA that was designed to deliver behavioral activation prompts to older adults with depression. Through user centered design (UCD), the investigators have adapted the model for remote support with the aid of VIPAs that provide psychoeducation, as well as features that support social, cognitive, and functional stimulation and reminders.

The intervention will be 8 weeks, with a 4-week follow-up. During 8-week intervention, participants will be able to use Amazon Echo Show 8 and the study's VIPA program to set goals, reminders, and the like to help with their mood. Participants will also be asked to completed associated assessments. If caregivers are involved, they will also be asked to complete assessments.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

  • Adults 65 years or older
  • English-speaking
  • Elevated depressive symptoms (PHQ-9 ≥ 10)
  • Have Wi-Fi access
  • Cognitively intact (Montreal Cognitive Assessment (MOCA) score ≥17)

or

Inclusion criteria:

  • Adults 18 years or older
  • English-speaking
  • Provide support to an older adult (65 or older)
  • Have access to Wi-Fi
  • Demonstrating capacity to consent
  • Cognitively intact (Montreal Cognitive Assessment (MOCA) score ≥17 if 65 years or older)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 2 patient groups

Digital Mental Health Intervention (DMHI)
Experimental group
Description:
Participants randomized to Arm 1 will be sent an Amazon Alexa device, with a newly designed VIPA treatment program installed, and will receive a guidebook to help the older adult understand the device and utilize the VIPA treatment program to its fullest potential.
Treatment:
Behavioral: VIPA Treatment Program
Control Treatment (CT)
Active Comparator group
Description:
Participants randomized to Arm 2 will be sent an Amazon Alexa device with guidebook to help the older adult understand how to use the device.
Treatment:
Behavioral: Alexa with Guidebook

Trial contacts and locations

1

Loading...

Central trial contact

Olga Barnas; Allison Carroll, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems